US Patent 9994637 Method of treating CD155 expressing cancers
Patent 9994637 was granted and assigned to Bristol-Myers Squibb on June, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9994637 Method of treating CD155 expressing cancers
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
